|
35
|
134
|
5ljbA |
Crystal structure of holo human crbp1 |
|
33
|
134
|
5ljkA |
Crystal structure of human apo crbp1 |
|
36
|
134
|
5ljcA |
Crystal structure of holo human crbp1 |
|
33
|
134
|
5ljhA |
Crystal structure of human apo crbp1/k40l mutant |
|
39
|
162
|
5lkeA |
Bovine beta-lactoglobulin complex with myristic acid, ambient pressure |
|
37
|
134
|
5ljeA |
Crystal structure of holo human crbp1/k40l,q108l mutant |
|
33
|
163
|
5k06A |
Recombinant bovine beta-lactoglobulin with uncleaved n-terminal methionine (rblgb) |
|
39
|
173
|
5khpA |
Tightening the recognition of tetravalent zr and th complexes by the siderophore-binding mammalian protein siderocalin for theranostic applications |
|
44
|
173
|
5jr8A |
Disposal of iron by a mutant form of siderocalin ngal |
|
40
|
173
|
5kidA |
Tightening the recognition of tetravalent zr and th complexes by the siderophore-binding mammalian protein siderocalin for theranostic applications |
|
41
|
173
|
5kicA |
Long-sought stabilization of berkelium(iv) in solution: an anomaly within the heavy actinide series |
|
35
|
162
|
5io5A |
Unliganded form of bovine beta-lactoglobulin, ambient pressure |
|
32
|
162
|
5io6A |
Bovine beta-lactoglobulin complex with dodecane, ambient pressure |
|
32
|
162
|
5io7A |
Bovine beta-lactoglobulin complex with dodecane at high pressure (0.43 gpa) |
|
33
|
135
|
5hz8A |
Fabp4_3 in complex with 6,8-dichloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid |
|
29
|
135
|
5hz9A |
Human fabp3 in complex with 6-chloro-2-methyl-4-phenyl-quinoline-3-carboxylic acid |
|
31
|
131
|
5hz6A |
Fabp4 in complex with 6-chloro-2-isopropyl-4-(3-isopropyl-phenyl)-quinoline-3-carboxylic acid |
|
35
|
134
|
5hz5A |
Fabp5 in complex with 6-chloro-4-phenyl-2-piperidin-1-yl-3-(1h-tetrazol-5-yl)-quinoline |
|
37
|
162
|
5htdA |
Recombinant bovine beta-lactoglobulin variant l1a/i2s with endogenous ligand (sblgb#1) |
|
37
|
133
|
5fenA |
Crystal structure of the q108k:k40l:t53c mutant of human cellular retinol binding protein ii in complex with all-trans-retinal after 24 hours of incubation at 1.55 angstrom resolution |
|
43
|
174
|
6gqzA |
Petrobactin-binding engineered lipocalin without ligand |
|
41
|
173
|
6gr0A |
Petrobactin-binding engineered lipocalin in complex with gallium-petrobactin |
|
41
|
162
|
6ghhA |
Thermodynamic, crystallographic and computational studies of non mammalian fatty acid binding to bovine b-lactoglobulin |
|
39
|
162
|
6gfsA |
Thermodynamic, crystallographic and computational studies of non mammalian fatty acid binding to bovine b-lactoglobulin |
|
43
|
162
|
6ge7A |
Thermodynamic, crystallographic and computational studies of non mammalian fatty acid binding to bovine b-lactoglobulin |
|
42
|
161
|
6gf9A |
Thermodynamic, crystallographic and computational studies of non mammalian fatty acid binding to bovine b-lactoglobulin |
|
42
|
162
|
6fxbA |
Bovine beta-lactoglobulin variant a at ph 4.0 |
|
28
|
133
|
6ew2A |
Human myelin protein p2 f57a mutant, tetragonal crystal form |
|
30
|
133
|
6ew5A |
Human myelin protein p2 f57a mutant, monoclinic crystal form |
|
27
|
133
|
6ew4A |
Human myelin protein p2 f57a mutant, monoclinic crystal form |
|
36
|
133
|
6c7zA |
Crystal structure of the q108k:k40l:t51v:r58f mutant of human cellular retinol binding protein ii in complex with synthetic ligand julolidine |
|
31
|
133
|
6aylA |
Human adipocyte lipid-binding protein fabp4 in complex with fluorescein |
|
34
|
133
|
6at8A |
1.1 angstrom resolution structure of human cellular retinol-binding protein iv |
|
30
|
134
|
6aq1A |
The crystal structure of human fabp3 |
|
41
|
159
|
5y5cA |
Crystal structure of dha bind to bovine beta-lactoglobulin |
|
32
|
136
|
5y0fA |
Crystal structure of human fabp4 complexed with ligand 2-fluoro-5-((4-methoxynaphthalene)-1-sulfonamido) benzoic acid |
|
33
|
131
|
5ce4A |
High resolution x-ray and neutron diffraction structure of h-fabp |
|
26
|
131
|
5c0nA |
Development of a monoclonal antibody targeting secreted ap2 to treat diabetes and fatty liver disease |
|
31
|
134
|
5bvtA |
Palmitate-bound pfabp5 |
|
32
|
132
|
5b29A |
The 1.28a structure of human fabp3 f16v mutant complexed with palmitic acid at room temperature |
|
35
|
133
|
4zj0A |
The crystal structure of monomer q108k:k40l:y60w crbpii bound to all-trans-retinal |
|
41
|
177
|
4zhhA |
Siderocalin-mediated recognition and cellular uptake of actinides |
|
41
|
177
|
4zhgA |
Siderocalin-mediated recognition and cellular uptake of actinides |
|
40
|
177
|
4zhfA |
Siderocalin-mediated recognition and cellular uptake of actinides |
|
38
|
133
|
4zguA |
Crystal structure of monomer y60w hcrbpii |
|
40
|
174
|
4zfxA |
Siderocalin-mediated recognition and cellular uptake of actinides |
|
41
|
175
|
4zhcA |
Siderocalin-mediated recognition and cellular uptake of actinides |
|
39
|
174
|
4zhdA |
Siderocalin-mediated recognition and cellular uptake of actinides |
|
35
|
137
|
4yfrA |
Crystal structure of the r111k:y134f:t54v:r132q:p39y:r59y mutant of human cellular retinoic acid binding protein ii with retinal at 1.95 angstrom resolution - uv irradiated crystal for 30 minutes - 1st cycle |
|
36
|
137
|
4ybpA |
Crystal structure of the r111k:y134f:t54v:r132q:p39q:r59y mutant of human cellular retinoic acid binding proteinii with retinal after 24 hour incubation at 1.83 angstrom resolution - thermodynamic product - 1st cycle |
